In a patient with mildly elevated serum calcium that normalized after stopping calcium supplementation, mild osteopenia, a neck ultrasound showing a suspicious parathyroid adenoma, and consistently normal intact parathyroid hormone levels, is a sestamibi scan indicated?

No Sestamibi Scan is Indicated in This Clinical Scenario

A sestamibi scan should not be performed in this patient because imaging for parathyroid adenomas is indicated solely for preoperative localization when surgery is planned, not for diagnosis, and this patient lacks biochemical evidence of primary hyperparathyroidism requiring surgical intervention. 1, 2

Key Diagnostic Principles

Imaging Has No Role in Diagnosis

• Imaging has no utility in confirming or excluding the diagnosis of primary hyperparathyroidism and should only be performed for preoperative localization when surgery is planned. 1, 2
• The American College of Radiology explicitly states that parathyroid imaging is performed solely to facilitate minimally invasive parathyroidectomy, not for diagnostic purposes. 1, 2

This Patient Does Not Meet Criteria for Primary Hyperparathyroidism

• The calcium normalized after stopping supplementation, indicating the hypercalcemia was exogenous (supplement-induced) rather than endogenous. 2
• Consistently normal intact PTH levels argue strongly against primary hyperparathyroidism, which requires elevated or inappropriately normal PTH in the setting of hypercalcemia. 2, 3, 4
• The biochemical diagnosis must precede any imaging consideration: hypercalcemia with normal or elevated PTH is required for diagnosis. 2

Understanding the Ultrasound Finding

The "Suspicious Adenoma" Requires Clinical Context

• Ultrasound can identify parathyroid-appearing structures, but without biochemical confirmation of hyperparathyroidism, such findings may represent normal parathyroid glands, incidental findings, or other structures. 3
• Even when parathyroid adenomas are present, they may be non-functioning and clinically insignificant if PTH and calcium are normal. 3, 4

Rare Exception: Occult Primary Hyperparathyroidism

• In extremely rare cases, primary hyperparathyroidism can present with normal total calcium but elevated ionized calcium and normal or mildly elevated PTH. 3, 4
• However, this patient's calcium normalized after stopping supplements, which excludes this diagnosis. 3

Clinical Pitfalls to Avoid

Do Not Order Sestamibi Based on Ultrasound Alone

• The sensitivity of sestamibi imaging is already decreased in the setting of mild hypercalcemia (which this patient no longer has), and it provides no diagnostic value without biochemical hyperparathyroidism. 5
• Sestamibi scans have sensitivities ranging from 67-86% even in confirmed primary hyperparathyroidism, and false positives can occur with thyroid nodules. 5, 6

Appropriate Next Steps

• Monitor serum calcium (corrected for albumin) and intact PTH levels periodically to ensure they remain normal now that supplementation has stopped. 2, 7
• If hypercalcemia recurs with normal calcium intake, then measure ionized calcium and repeat PTH to reassess for primary hyperparathyroidism. 2, 3
• Consider measuring 25-OH vitamin D levels, as vitamin D deficiency can lead to secondary hyperparathyroidism and may have prompted the original calcium supplementation for osteopenia. 2, 7

When Sestamibi Would Be Indicated

• Only if biochemical primary hyperparathyroidism is confirmed (persistent hypercalcemia with elevated or inappropriately normal PTH) AND surgery is being planned should preoperative localization with sestamibi (preferably with SPECT/CT) and/or ultrasound be performed. 5, 1, 2
• Dual-phase sestamibi with SPECT/CT has pooled sensitivity of 86% and is the preferred imaging modality for preoperative localization. 5